SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 8 06:34 ET
SINOMAB BIO-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023; CHANGE IN USE OF PROCEEDS; PROPOSED AMENDMENT TO THE 2022 SHARE OPTION SCHEME; AND PROPOSED REFRESHMENT OF SCHEME MANDATE LIMIT AND SERVICE PROVIDER SUBLIMIT
Mar 25 09:38 ET
SINOMAB BIO-B: DATE OF BOARD MEETING
Mar 12 06:27 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 5 03:53 ET
SINOMAB BIO-B: Letter to Non-Registered Shareholders - Arrangements of Electronic Dissemination of Corporate Communications
Feb 8 23:12 ET
SINOMAB BIO-B: Letter to Registered Shareholders - Arrangements of Electronic Dissemination of Corporate Communications
Feb 8 23:08 ET
SINOMAB BIO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Feb 7 04:52 ET
SINOMAB BIO-B: APPOINTMENT OF EXECUTIVE DIRECTOR
Feb 7 04:49 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 6 03:36 ET
SINOMAB BIO-B: Next Day Disclosure Return
Jan 31 09:25 ET
SINOMAB BIO-B: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Jan 31 09:22 ET
SINOMAB BIO-B: Next Day Disclosure Return
Jan 12 07:02 ET
SINOMAB BIO-B: COMPLETION OF CERTAIN SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Jan 12 06:59 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 4 03:49 ET
SINOMAB BIO-B: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Dec 14, 2023 09:40 ET
SINOMAB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 5, 2023 03:31 ET
SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT FIRST COHORT OF THE HEALTHY SUBJECTS DOSED IN A PHASE I CLINICAL TRIAL OF SM17 IN CHINA
Nov 27, 2023 08:07 ET
SINOMAB BIO-B: GRANT OF SHARE OPTIONS
Nov 16, 2023 05:15 ET
SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM03 (SUCIRASLIMAB) FOR THE TREATMENT OF ALZHEIMER''S DISEASE ACCEPTED BY NMPA CDE
Nov 15, 2023 06:51 ET
SINOMAB BIO-B: GRANT OF SHARE OPTIONS
Nov 6, 2023 05:41 ET
No Data
No Data